R&D Procurement & Sourcing in Pharma Summit

R&D investment continues to climb, especially in the clinical development space, with major pharmaceutical players such as Merck, Roche, and Johnson & Johnson leading 2024’s global R&D spending. However, this growth occurs against a backdrop of growing global uncertainty. Shifting tariff policies, unpredictable trade agreements, and broader geopolitical instability are creating new pressures on procurement teams to protect budgets and remain resilient in light of current supply chain instability. It has never been more important for R&D procurement and sourcing professionals across biopharma to unite and understand how to futureproof against such pressures and adjust their sourcing strategies, whilst ultimately achieving corporate milestones.